Stock Price
1,346.00
Daily Change
-12.10 -0.89%
Monthly
1.32%
Yearly
-4.37%
Q1 Forecast
1,315.62

Cipla reported INR2.98B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 398K 204K Sep/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 2.98B 454.6M Sep/2025
Dr.Reddys Laboratories INR 11.61B 29M Dec/2025
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Sangamo BioSciences USD 0 0 Jun/2022
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
TherapeuticsMD USD 0 0 Mar/2022
UPL INR 182.37B 10.19B Sep/2025